Bibliographic Details
| Title: |
mTOR pathway – a potential therapeutic target in stroke. |
| Authors: |
Melanis, Konstantinos, Stefanou, Maria-Ioanna, Themistoklis, Konstantinos M., Papasilekas, Themistoklis |
| Source: |
Therapeutic Advances in Neurological Disorders; 8/9/2023, p1-15, 15p |
| Subject Terms: |
STROKE treatment, MTOR protein, RAPAMYCIN, THREONINE, ISCHEMIC stroke, AUTOPHAGY |
| Abstract: |
Stroke is ranked as the second leading cause of death worldwide and a major cause of long-term disability. A potential therapeutic target that could offer favorable outcomes in stroke is the mammalian target of rapamycin (mTOR) pathway. mTOR is a serine/threonine kinase that composes two protein complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), and is regulated by other proteins such as the tuberous sclerosis complex. Through a significant number of signaling pathways, the mTOR pathway can modulate the processes of post-ischemic inflammation and autophagy, both of which play an integral part in the pathophysiological cascade of stroke. Promoting or inhibiting such processes under ischemic conditions can lead to apoptosis or instead sustained viability of neurons. The purpose of this review is to examine the pathophysiological role of mTOR in acute ischemic stroke, while highlighting promising neuroprotective agents such as hamartin for therapeutic modulation of this pathway. The therapeutic potential of mTOR is also discussed, with emphasis on implicated molecules and pathway steps that warrant further elucidation in order for their neuroprotective properties to be efficiently tested in future clinical trials. [ABSTRACT FROM AUTHOR] |
|
Copyright of Therapeutic Advances in Neurological Disorders is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
